No 03 2018

The patent covers the use of AC01 for the treatment of heart failure with reduced ejection fraction (HFrEF).

The United States Patent and Trademark Office (USPTO) has granted a patent covering Alligator’s bispecific antibody format.

For decades, Duchenne muscular dystrophy was a diagnosis without effective treatment. Through pioneering work on RNA-based therapies that allow cells to bypass faulty genes, Muntoni helped demonstrate that even severe inherited diseases can be modified at their molecular source — a shift that reshaped genetic medicine.

ClinStorage has entered a partnership with Rubicon Healthcare Partners, which will become the company’s new majority owner.

Torsten Malmström has assumed the position of Director CMC & Supply.

Elicera Therapeutics' Chief Scientific Officer has been named Cancer Researcher of the Year 2026 by the Swedish Cancer Society (Cancerfonden).

Oncopeptides has achieved key regulatory agreement with both the Swedish and Norwegian Medical Products Agencies regarding the design of its planned “Window-of-Opportunity” study evaluating a Peptide Drug Conjugate (PDC) in glioblastoma.